STOCK TITAN

DNLI (NASDAQ: DNLI) insider plans 150,000-share Rule 144 sale

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

A person named Carole Ho has filed a Rule 144 notice indicating an intention to sell 150,000 shares of common stock through Morgan Stanley Smith Barney LLC on NASDAQ. The filing lists an aggregate market value of 3,176,970.00 for these shares and shows 146,661,833 shares outstanding.

The notice also reports that on 02/04/2026 options were exercised under a registered plan to acquire 36,042 and 113,958 common shares for cash. In the past three months, the same seller disposed of 150,000 common shares for 3,324,060.00.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the DNLI Rule 144 filing disclose?

The filing shows a planned sale of 150,000 common shares through Morgan Stanley Smith Barney LLC on NASDAQ, with an aggregate market value of about 3,176,970.00, plus recent option exercises and prior share sales by the same seller.

How many DNLI shares is the insider planning to sell under this notice?

The notice covers a planned sale of 150,000 common shares. These shares are to be sold on the NASDAQ market, with the filing indicating an aggregate market value of 3,176,970.00 based on the quoted market price at the time of the notice.

What recent DNLI insider sales are reported in the past three months?

The document reports that Carole Ho sold 150,000 common shares on 02/03/2026, generating gross proceeds of 3,324,060.00. This historical sale information is required to be aggregated with the newly planned sales under Rule 144 disclosure rules.

What option exercises related to DNLI stock are disclosed in this filing?

On 02/04/2026, options under a registered plan were exercised to acquire 36,042 and 113,958 common shares for cash. These acquisitions are listed as the source of the securities that may be sold under the Rule 144 notice.

Which broker is handling the planned DNLI share sale under Rule 144?

The planned sale of 150,000 common shares is to be handled by Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004, with the shares listed for trading on the NASDAQ exchange.

How many DNLI shares are reported as outstanding in the Rule 144 notice?

The filing states that there are 146,661,833 common shares outstanding. This figure provides context for the planned 150,000-share sale but is a baseline capital structure number rather than an amount being registered or newly issued.
Denali Therapeut

NASDAQ:DNLI

DNLI Rankings

DNLI Latest News

DNLI Latest SEC Filings

DNLI Stock Data

3.25B
140.31M
9.83%
96.25%
9.4%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States
SOUTH SAN FRANCISCO